Skip to main content
logo
Biomark Diagnostics Inc. (FRA:20B)
Germany flag Germany · Delayed Price · Currency is EUR
0.2860
0.00 (0.00%)
Last updated: Aug 24, 2026, 8:04 AM CET

Biomark Diagnostics Financials Overview

Millions CAD. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
0.060.060.150.160.150.04
Revenue Growth
-61.23%-61.23%-5.52%6.34%249.38%-
Gross Profit
0.060.060.150.160.150.04
Operating Income
-1.72-1.72-2.05-1.71-1.84-1.28
Net Income
-1.48-1.48-1.93-1.43-1.84-1.45
Earnings Per Share
-0.01-0.01-0.02-0.02-0.02-0.02
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
1.011.012.480.160.070.38
Total Debt
1.421.421.121.551.651.97
Net Cash (Debt)
-0.41-0.411.36-1.39-1.58-1.58
Net Cash Growth
------
Net Cash Per Share
-0.00-0.000.01-0.02-0.02-0.02

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
-1.09-1.09-1.09-0.98-0.91-1.2
Capital Expenditures
-0-0-0-0-0.01-0.06
Free Cash Flow
-1.09-1.09-1.1-0.99-0.92-1.26
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-2877.96%-2877.96%-1327.45%-1046.96%-1198.95%-2922.50%
Pretax Margin
-2470.76%-2470.76%-1249.73%-874.52%-1200.21%-3309.36%
Profit Margin
-2470.76%-2470.76%-1249.73%-874.52%-1200.21%-3309.36%
FCF Margin
-1828.20%-1828.20%-711.12%-604.65%-599.20%-2875.13%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PS Ratio
819.81961.85145.04152.12100.50356.91